First Time Loading...
T

Tempo Scan Pacific Tbk PT
IDX:TSPC

Watchlist Manager
Tempo Scan Pacific Tbk PT
IDX:TSPC
Watchlist
Price: 2 000 IDR 1.01% Market Closed
Updated: Jun 3, 2024
Section:
 

Relative Value

The Relative Value of one TSPC stock under the Base Case scenario is 1 876.82 IDR. Compared to the current market price of 2 000 IDR, Tempo Scan Pacific Tbk PT is Overvalued by 6%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TSPC Relative Value
Base Case
1 876.82 IDR
Overvaluation 6%
Relative Value
Price
T
Worst Case
Base Case
Best Case

Valuation Multiples

0.7
P/S
P/S
Price to Sales
0.7
vs History
1
vs Industry
79
Median 3Y
0.5
Median 5Y
0.5
Industry
2.4
More Details
7.7
P/E
P/E
Price to Earnings
7.7
vs History
26
vs Industry
39
Median 3Y
7
Median 5Y
7.2
Industry
22.4
More Details
7.5
P/OCF
P/OCF
Price to OCF
7.5
vs History
57
vs Industry
40
Median 3Y
8.5
Median 5Y
7.7
Industry
16.9
More Details
17.9
P/FCFE
P/FCFE
Price to FCFE
17.9
vs History
19
vs Industry
24
Median 3Y
14.9
Median 5Y
10.8
Industry
22.6
More Details
1.2
P/B
P/B
Price to Book Value
1.2
vs History
1
vs Industry
57
Median 3Y
0.9
Median 5Y
0.9
Industry
2
More Details
0.5
EV/S
EV/S
Enterprise Value to Sales
0.5
vs History
1
vs Industry
85
Median 3Y
0.3
Median 5Y
0.3
Industry
2.5
More Details
1.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.3
vs History
1
vs Industry
79
Median 3Y
1
Median 5Y
1
Industry
5.1
More Details
5.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
5.9
vs History
20
vs Industry
44
Median 3Y
3.9
Median 5Y
3.9
Industry
13.3
More Details
5.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
5.9
vs History
20
vs Industry
43
Median 3Y
3.9
Median 5Y
3.9
Industry
16.6
More Details
5.3
EV/OCF
EV/OCF
Enterprise Value to OCF
5.3
vs History
52
vs Industry
45
Median 3Y
5.6
Median 5Y
5.4
Industry
15.7
More Details
7.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
7.3
vs History
47
vs Industry
32
Median 3Y
8.2
Median 5Y
7.1
Industry
17.7
More Details
1
EV/IC
EV/IC
Enterprise Value to IC
1
vs History
1
vs Industry
58
Median 3Y
0.7
Median 5Y
0.7
Industry
1.9
More Details

Multiples Across Competitors

TSPC Competitors Multiples
Tempo Scan Pacific Tbk PT Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
ID
Tempo Scan Pacific Tbk PT
IDX:TSPC
9T IDR 0.7 7.7 5.9 5.9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
779.7B USD 21.7 127 62.1 70.7
DK
Novo Nordisk A/S
CSE:NOVO B
4.1T DKK 16.8 45.9 34.2 37.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
353B USD 4.1 9.2 11.3 14.8
US
Merck & Co Inc
NYSE:MRK
318B USD 5.2 137.9 34.4 56.2
UK
AstraZeneca PLC
LSE:AZN
189.3B GBP 5.1 38.1 174.7 278.7
CH
Roche Holding AG
SIX:ROG
185.6B CHF 3.2 16.1 9.2 10.9
CH
Novartis AG
SIX:NOVN
182.1B CHF 3.4 11.5 8.8 12.8
US
Pfizer Inc
NYSE:PFE
162.4B USD 2.9 -525.6 12.7 20.6
P/E Multiple
Earnings Growth
ID
T
Tempo Scan Pacific Tbk PT
IDX:TSPC
Average P/E: 49.2
7.7
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
127
364%
DK
Novo Nordisk A/S
CSE:NOVO B
45.9
83%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Johnson & Johnson
NYSE:JNJ
9.2
-21%
US
Merck & Co Inc
NYSE:MRK
137.9
7 598%
UK
AstraZeneca PLC
LSE:AZN
38.1
175%
CH
Roche Holding AG
SIX:ROG
16.1
28%
CH
Novartis AG
SIX:NOVN
11.5
17%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -525.6
683%

See Also

Summary
TSPC intrinsic value, competitors valuation, and company profile.
DCF Valuation
TSPC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TSPC stock valuation using valuation multiples.
Wall Street Estimates
TSPC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TSPC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 143,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.